Exit
Duke Street sells Kent Pharma to Phoenix Labs
Duke Street is selling Kent Pharma, an Ashford-based distributor of specialty and generic medicines in the UK and Ireland, to Phoenix Labs.
Kent Pharma is headquartered in Ashford, UK, and distributes specialty and generic pharmaceuticals across the UK and Ireland. The company is one of the top suppliers of injectables to NHS hospitals.
Deal facts
- Target
- Kent Pharma
- Business
- Specialty and generic pharmaceutical distributor serving the UK and Ireland, and a leading supplier of injectables to NHS hospitals
- Buyer
- Phoenix Labs
- Seller
- Duke Street
- Deal type
- Exit
- Headquarters
- Ashford, UK
- Status
- Announced
- Announced
- Wednesday, September 23, 2026
Sources
- Private Equity InternationalSep 23, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.